Alterome Therapeutics, Inc. Recognized at Goldman Sachs Builders and Innovators Summit Alterome Therapeutics, Inc., a biopharmaceutical company specializing in next-generation small molecule targeted therapies for cancer, announced that Eric Murphy,…
iProov Reports 63% Transaction Growth Amid Rising Demand for Biometric Solutions iProov, a leader in biometric identity solutions, announced a remarkable 63% increase in transaction volume on its platform from…
Minze Health Secures $5.3 Million in Funding to Advance Digital Health Solutions for Urology Minze Health, a leader in digital health solutions tailored for urology, has successfully raised $5.3 million…
Modivcare Partners with Tenovi to Enhance Respiratory Care Using Adherium’s Hailie® Smart Inhalers Modivcare Inc., a prominent technology-enabled healthcare services company, has announced a partnership with Tenovi, a pioneer in…
Sage Therapeutics, Inc. (Nasdaq: SAGE) has unveiled a strategic reorganization initiative aimed at prioritizing the commercialization of ZURZUVAE® for postpartum depression while sharpening its focus on pipeline development, including the…
Marinus Pharmaceuticals, Inc. (Nasdaq: MRNS), a company focused on developing innovative therapies for seizure disorders, has shared new data from its Phase 3 RAISE trial on intravenous (IV) ganaxolone for…
Artesunate AMIVAS, the first fully licensed treatment for severe malaria in Europe, is now available for purchase across Europe and the U.K. through Nordic Prime in Denmark. Approved by the…
Helfie AI, a global leader in mobile health technology, has strengthened its Board of Directors with the addition of two healthcare veterans. Antonin (Tony) de Fougerolles, PhD, a distinguished scientist…
Viatris Signs Exclusive Licensing Deal with Lexicon for Sotagliflozin Outside U.S. and Europe PITTSBURGH, Oct. 16, 2024 /PRNewswire/ — Viatris Inc. (Nasdaq: VTRS) has reached an exclusive licensing agreement with…
Shimadzu Corporation, Eisai Co., Ltd., Oita University, and the Usuki City Medical Association have demonstrated that blood biomarkers can effectively predict amyloid beta (Aβ) accumulation in the brain, a major…
Shionogi & Co., Ltd. recently presented findings at IDWeek 2024 from the PROVE study, the largest global real-world evidence study on cefiderocol (marketed as Fetroja®/Fetcroja®), a siderophore cephalosporin antibiotic for…
WuXi Biologics (“WuXi Bio”) (2269.HK), a global leader in Contract Research, Development, and Manufacturing Organization (CRDMO), announced its fourth consecutive Platinum Award from The Asset ESG (Environmental, Social, and Governance)…